Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Diabetes Research Society
DiabetOmics Medical
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years or older, male and female 2. Subjects confirmed, suspected or with symptoms of Rheumatoid Arthritis 3. Smoking or non-smoking 4. Subjects willing for participating in the study and providing informed consent
Exclusion criteria
Exclusion criteria: 1. Subjects unwilling to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected Outcomes are: 1. Significant positive correlation between presence or absence of (blood and salivary) IgG antibodies (against citrullinated albumin) and, severity and duration of disease after onset of symptoms. 2. Positive association in individuals who have specific disease (RA with elevated ACCP/ACPA or RF) and then antibodies remain detrimental for the remainder of the disease period, warranting more frequent and regular monitoring for anti-cit Alb antibodies.Timepoint: first visit only, cross-sectional study | — |
Secondary
| Measure | Time frame |
|---|---|
| The expected secondary study outcomes are: 1. Direct relation between presence of antibodies in blood and oral fluid. 2. IgG antibodies in blood are comparably expressed and demonstrated in oral fluid (GCF)Timepoint: first visit only, cross-sectional study | — |
Countries
India
Contacts
Public ContactPaturi Vishnupriya Rao
Kumudini Diabetes Research Center
Outcome results
None listed